Unternehmen Blue Water Ventures International, Inc. Other OTC
Aktien
BWVI
US09609E1055
BWVI
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Neilank K. Jha
CEO | Chief Executive Officer | - | 12.12. |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
Chadwick Harman
COO | Chief Operating Officer | - | - |
Julian Bailes
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anish Tuteja
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Zapolin
PRN | Corporate Officer/Principal | - | - |
Aric Logsdon
PRN | Corporate Officer/Principal | - | 29.11.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bruce Cassidy
BRD | Director/Board Member | 74 | - |
Michael Gurin
BRD | Director/Board Member | - | - |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
Neilank K. Jha
CEO | Chief Executive Officer | - | 12.12. |
Julian Bailes
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chadwick Harman
COO | Chief Operating Officer | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 276 427 437 | 68 797 013 ( 24,89 %) | 0 | 24,89 % |
Aktie B | 0 | 161 700 | 0 | 0 |
Unternehmenskontakt
Psycheceutical Bioscience, Inc.
515 East Las Olas Boulevard Suite 120
33301, Fort Lauderdale
+
http://www.psycheceutical.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+29,77 % | 49,18 Mrd. | |
+1,00 % | 42,11 Mrd. | |
+50,47 % | 40,37 Mrd. | |
-5,26 % | 28,85 Mrd. | |
+13,68 % | 26,09 Mrd. | |
-22,99 % | 18,71 Mrd. | |
+8,22 % | 13,26 Mrd. | |
+32,41 % | 12,32 Mrd. | |
-1,62 % | 11,99 Mrd. |